(A) Auxiliary marking points to ensure complete and accurate seating of the prosthesis. by Long Li (6555)

DataSheet1_Decreasing viscosity and increasing accessible load by replacing classical diluents with a hydrotrope in liquid–liquid extraction.docx by Asmae El Maangar (19690522)

“…We show that using hydrotropes as a diluent decreases the viscosity of solutions by more than a factor of ten, even under high load by extracted cations. …”

PNGaseF-Generated N‑Glycans Adduct onto Peptides in the Gas Phase by Valentina Rangel-Angarita (16972992)

Subjects:

PNGaseF-Generated N‑Glycans Adduct onto Peptides in the Gas Phase by Valentina Rangel-Angarita (16972992)

Subjects:

PNGaseF-Generated N‑Glycans Adduct onto Peptides in the Gas Phase by Valentina Rangel-Angarita (16972992)

Subjects:

PNGaseF-Generated N‑Glycans Adduct onto Peptides in the Gas Phase by Valentina Rangel-Angarita (16972992)

Subjects:

PNGaseF-Generated N‑Glycans Adduct onto Peptides in the Gas Phase by Valentina Rangel-Angarita (16972992)

Subjects:

PNGaseF-Generated N‑Glycans Adduct onto Peptides in the Gas Phase by Valentina Rangel-Angarita (16972992)

Subjects:

PNGaseF-Generated N‑Glycans Adduct onto Peptides in the Gas Phase by Valentina Rangel-Angarita (16972992)

Subjects:

PNGaseF-Generated N‑Glycans Adduct onto Peptides in the Gas Phase by Valentina Rangel-Angarita (16972992)

Subjects:

PNGaseF-Generated N‑Glycans Adduct onto Peptides in the Gas Phase by Valentina Rangel-Angarita (16972992)

Subjects:

PNGaseF-Generated N‑Glycans Adduct onto Peptides in the Gas Phase by Valentina Rangel-Angarita (16972992)

Subjects:

PNGaseF-Generated N‑Glycans Adduct onto Peptides in the Gas Phase by Valentina Rangel-Angarita (16972992)

Subjects:

PNGaseF-Generated N‑Glycans Adduct onto Peptides in the Gas Phase by Valentina Rangel-Angarita (16972992)

Subjects:

Overview of the WeARTolerance program. by Ana Beato (20489933)

“…The quantitative results from Phase 1 demonstrated a decreasing trend in all primary outcomes. …”

Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…In addition, compound <b>E35</b> significantly inhibited colony formation and migration, as well as arrested the cell cycle at the S-phase. Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…In addition, compound <b>E35</b> significantly inhibited colony formation and migration, as well as arrested the cell cycle at the S-phase. Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…In addition, compound <b>E35</b> significantly inhibited colony formation and migration, as well as arrested the cell cycle at the S-phase. Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…In addition, compound <b>E35</b> significantly inhibited colony formation and migration, as well as arrested the cell cycle at the S-phase. Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …”